| Income Statement |
| Total Revenue | 297.79M |
|
| Revenues (USD) | 297.79M |
| Cost of Revenue | 129.46M |
| Gross Profit | 168.33M |
| Operating Expenses | 102.10M |
| Research and Development Expense | 34.77M |
| Selling, General and Administrative Expense | 57.44M |
| Operating Income | 66.23M |
| Income Tax Expense | 16.86M |
| Net Income | 50.35M |
| Net Income Common Stock | 50.35M |
| Net Income Common Stock (USD) | 50.35M |
| Consolidated Income | 50.35M |
| Earnings per Basic Share | 0.86 |
| Earnings per Basic Share (USD) | 0.86 |
| Earnings per Diluted Share | 0.85 |
| Earning Before Interest & Taxes (EBIT) | 67.21M |
| Earning Before Interest & Taxes (USD) | 67.21M |
| Weighted Average Shares | 58.76M |
| Weighted Average Shares Diluted | 59.00M |
| Balance Sheet |
| Cash and Equivalents | 186.11M |
| Cash and Equivalents (USD) | 186.11M |
| Trade and Non-Trade Receivables | 218.88M |
| Current Assets | 467.06M |
| Property, Plant & Equipment Net | 70.81M |
| Total Assets | 698.65M |
| Total Debt | 53.88M |
| Current Liabilities | 475.05M |
| Debt Non-Current | 53.88M |
| Total Liabilities | 541.14M |
| Accumulated Retained Earnings (Deficit) | 193.95M |
| Accumulated Other Comprehensive Income | -37.03M |
| Shareholders Equity | 157.51M |
| Shareholders Equity (USD) | 157.51M |
| Assets Non-Current | 231.59M |
| Total Debt (USD) | 53.88M |
| Deferred Revenue | 343.21M |
| Goodwill and Intangible Assets | 62.24M |
| Liabilities Non-Current | 66.08M |
| Trade and Non-Trade Payables | 30.73M |
| Tax Assets | 50.86M |
| Tax Liabilities | 168.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.63M |
| Net Cash Flow from Financing | -127.09M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -40.02M |
| Capital Expenditure | -1.00M |
| Issuance (Purchase) of Equity Shares | -127.09M |
| Net Cash Flow from Investing | -1.00M |
| Net Cash Flow from Operations | 90.68M |
| Effect of Exchange Rate Changes on Cash | -2.61M |
| Share Based Compensation | 29.36M |